Pharmaceutical Preparation Manufacturing Industry - Market Size, Trends, and Growth - 2025-2030
Industry Overview
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
Source: U.S. Census BureauMarket Size and Industry Forecast
This research report analyzes the market size and trends in the Pharmaceutical Preparation Manufacturing industry. It shows overall market size from 2020 to the present, and predicts industry growth through 2030. Revenues data include both public and private companies.
| Historical | Forecasted |
|---|
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|
| Market Size (Total Revenue) | Included in Report |
| % Growth Rate |
| Number of Companies |
| Total Employees |
| Average Revenue per Company |
| Average Employees per Company |
Source: U.S. government financial dataIndustry Revenue ($ Billions)
Industry Forecast ($ Billions)
Advanced econometric models forecast five years of industry growth based on short- and long-term trend analysis. Market size includes revenue generated from all products and services sold within the industry.
Geographic Breakdown by U.S. State
Market size by state reveals local opportunity through the number of companies located in the region. Each state's growth rate is affected by regional economic conditions. Data by state can be used to pinpoint profitable and nonprofitable locations for Pharmaceutical Preparation Manufacturing companies in the United States.
Pharmaceutical Preparation Manufacturing Revenue by State
Distribution by Company Size
| Company Size | All Industries | Pharmaceutical Preparation Manufacturing |
|---|
| Small Business (< 5 Employees) | Included |
| Small Business (5 - 20) |
| Midsized Business (20 - 100) |
| Large Business (100 - 500) |
| Enterprise (> 500) |
Pharmaceutical Preparation Manufacturing Industry Income Statement (Average Financial Metrics)
Financial statement analysis determines averages for the following industry forces:
- Cost of goods sold
- Compensation of officers
- Salaries and wages
- Employee benefit programs
- Rent paid
- Advertising and marketing budgets
The report includes a traditional income statement from an "average" company (both public and private companies are included).
| Industry Average | Percent of Sales |
|---|
| Total Revenue | Included |
| Operating Revenue |
| Cost of Goods Sold (COGS) |
| Gross Profit |
| Operating Expenses |
| Operating Income |
| Non-Operating Income |
| Earnings Before Interest and Taxes (EBIT) |
| Interest Expense |
| Earnings Before Taxes |
| Income Tax |
| Net Profit |
Average Income Statement
Cost of Goods Sold
Salaries, Wages, and Benefits
Rent
Advertising
Depreciation and Amortization
Officer Compensation
Net Income
Financial Ratio Analysis
Financial ratios allow a company's performance to be compared against that of its peers.
| Financial Ratio | Industry Average |
|---|
| Profitability Ratios | Included |
| Profit Margin |
| ROE |
| ROA |
| Liquidity Ratios |
| Current Ratio |
| Quick Ratio |
| Activity Ratios |
| Average Collection Period |
| Asset Turnover Ratio |
| Receivables Turnover Ratio |
| Inventory Conversion Ratio |
Products and Services Mix
Product lines and services in the Pharmaceutical Preparation Manufacturing industry accounting for the largest revenue sources.
| Product Description | Description | Revenue
($ Millions) |
|---|
Pharmaceutical preparation manufacturing | Included |
Affecting neoplams, endocrine system, & metabolic diseases |
Acting on the central nervous system and the sense organs |
Acting on the cardiovascular system, for human use |
Acting on the respiratory system, for human use |
Acting on the digestive/genito-urinary systems, for human use |
Pharmaceutical preparations, acting on skin, for human use |
Vitamin, nutrient, and hematinic preparations, for human use |
Affecting parasitic and inefective diseases, for human use |
Veterinary use, incl. medicinal premixes/pet care products |
Salary information for employees working in the Pharmaceutical Preparation Manufacturing industry.
| Title | Percent of Workforce | Bottom Quartile | Average (Median) Salary | Upper Quartile |
|---|
| Management Occupations | 11% | Included |
| Chief Executives | 0% |
| General and Operations Managers | 2% |
| Business and Financial Operations Occupations | 8% |
| Business Operations Specialists | 7% |
| Architecture and Engineering Occupations | 6% |
| Life, Physical, and Social Science Occupations | 16% |
| Life Scientists | 6% |
| Physical Scientists | 6% |
| Chemists and Materials Scientists | 6% |
| Chemists | 6% |
| Office and Administrative Support Occupations | 8% |
| Production Occupations | 32% |
| Other Production Occupations | 26% |
| Packaging and Filling Machine Operators and Tenders | 9% |
| Packaging and Filling Machine Operators and Tenders | 9% |
Government Contracts
The federal government spent an annual total of
$9,954,982,261 on the pharmaceutical preparation manufacturing industry. It has awarded 14,814 contracts to 370 companies, with an average value of $26,905,357 per company.
Top Companies in Pharmaceutical Preparation Manufacturing and Adjacent Industries
| Company | Address | Revenue
($ Millions) |
|---|
Included |
